Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: A Microsimulation Analysis
Indexado
WoS WOS:001147333600001
Scopus SCOPUS_ID:85165709545
DOI 10.1016/J.CGH.2023.05.028
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Background & Aims: Gastric intestinal metaplasia (GIM) is associated with a higher risk of noncardia intestinal gastric adenocarcinoma (GA). The aim of this study was to estimate lifetime benefits, complications, and cost-effectiveness of GIM surveillance using esophagogastroduodenoscopy (EGD). Methods: We developed a semi-Markov microsimulation model of patients with incidentally detected GIM, to compare the effectiveness of EGD surveillance with no surveillance at 10-year, 5-year, 3-year, 2-year, and 1-year intervals. We modeled a simulated cohort of 1,000,000 US individuals aged 50 with incidental GIM. Outcome measures were lifetime GA incidence, mortality, number of EGDs, complications, undiscounted life-years gained, and incremental cost-effectiveness ratio with a willingness-to-pay threshold of $100,000/quality-adjusted life-year (QALY). Results: In the absence of surveillance, the model simulated 32.0 lifetime GA cases and 23.0 lifetime GA deaths per 1000 individuals with GIM, respectively. Among surveilled individuals, simulated lifetime GA incidence (per 1000) decreased with shorter surveillance intervals (10-year to 1-year, 11.2–6.1) as did GA mortality (7.4–3.6). Compared with no surveillance, all modeled surveillance intervals yielded greater life expectancy (87–190 undiscounted life-years gained per 1000); 5-year surveillance provided the greatest number of life-years gained per EGD performed and was the cost-effective strategy ($40,706/QALY). In individuals with risk factors of family history of GA or anatomically extensive, incomplete-type GIM intensified 3-year surveillance was cost-effective (incremental cost-effectiveness ratio $28,156/QALY and $87,020/QALY, respectively). Conclusions: Using microsimulation modeling, surveillance of incidentally detected GIM every 5 years is associated with reduced GA incidence/mortality and is cost-effective from a health care sector perspective. Real-world studies evaluating the impact of GIM surveillance on GA incidence and mortality in the United States are needed.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Gastroenterology & Hepatology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Thiruvengadam, Nikhil R. Hombre Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos
2 Gupta, Shashank - Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos
3 Buller, Seth Hombre Loma Linda University School of Medicine - Estados Unidos
Loma Linda Univ - Estados Unidos
4 Awad, Imad Hombre Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos
5 Gandhi, Devika - Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos
6 Ibarra, Allison Mujer University of California, San Diego - Estados Unidos
Univ Calif San Diego - Estados Unidos
7 Latorre, Gonzalo Hombre Pontificia Universidad Católica de Chile - Chile
8 RIQUELME-PEREZ, ARNOLDO JAVIER Hombre Pontificia Universidad Católica de Chile - Chile
Núcleo Milenio de Sociomedicina - Chile
Ctr Prevenc & Control Canc CECAN - Chile
9 Kochman, Michael L. Hombre University of Pennsylvania Perelman School of Medicine - Estados Unidos
Perelman Sch Med - Estados Unidos
10 Cote, Gregory Hombre Oregon Health & Science University - Estados Unidos
Oregon Hlth & Sci Univ - Estados Unidos
11 Shah, Shailja C. - University of California, San Diego - Estados Unidos
VA San Diego Healthcare System - Estados Unidos
Univ Calif San Diego - Estados Unidos
Vet Affairs San Diego Healthcare Syst - Estados Unidos
12 Saumoy, Monica Mujer Penn Medicine Princeton Medical Center - Estados Unidos
Penn Med Princeton Med Ctr - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
NIH
Fondo Nacional de Desarrollo Científico y Tecnológico
National Institutes of Health
Pontificia Universidad Católica de Chile
European Commission
European Union
Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
Horizon 2020 Framework Programme
U.S. Department of Veterans Affairs
American Gastroenterological Association
Chilean Agency of Research and Development
Arnoldo Riquelme
Shashank Gupta
Allison Ibarra
Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP
Concurso de politicas publicas 2022 Pontificia Universidad Catolica de Chile
Veterans Affairs Career Development Award
Chilean Agency of Research and Development Grant FONDECYT
American Gastroenterological Association Research Scholar Award

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Funding Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union’s Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de políticas públicas 2022 Pontificia Universidad Católica de Chile.
Funding Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union’s Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de políticas públicas 2022 Pontificia Universidad Católica de Chile.
Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union's Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de politicas publicas 2022 Pontificia Universidad Catolica de Chile.

Muestra la fuente de financiamiento declarada en la publicación.